Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tunodafil Hydrochloride Tablets in Patients With Erectile Dysfunction
NCT07692867Phase 3Completed
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Apr 2021
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 3 trial of tunodafil hydrochloride in erectile dysfunction (ED), sponsored by Yangtze River Pharmaceutical Group. Started Apr 2021; status: completed.
02
Drugs
tunodafil hydrochloride
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT07692867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07692867.